16.54
price down icon2.19%   -0.37
after-market 시간 외 거래: 16.45 -0.09 -0.54%
loading

Edgewise Therapeutics Inc (EWTX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
2.63%
34.75
33.86 29.45 25.34 25.70
Operating Income/Loss
2.63%
-34.75
-33.86 -29.45 -25.34 -25.70
Income/Loss From Continuing Operations Before Tax
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Income/Loss From Continuing Operations After Tax
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Net Income/Loss
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24,620%
87.57
0.3542 63.46 63.38 63.27
Diluted Average Shares
24,620%
87.57
0.3542 63.46 63.38 63.27
Basic Earnings Per Share
29.79%
-0.33
-0.47 -0.41 -0.34 -0.36
Diluted Earnings Per Share
29.79%
-0.33
-0.47 -0.41 -0.34 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
자본화:     |  볼륨(24시간):